CAPTRUST Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
CAPTRUST Financial Advisors's ARKG Position: Q1 2025 in Review
CAPTRUST Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 16,953 shares — an estimated $399K sold.
CAPTRUST Financial Advisors first reported a position in ARKG in Q2 2020 and held it in 18 quarters. The position peaked at $1.73M in Q3 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- CAPTRUST Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 16,953 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $399K.
- CAPTRUST Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 18 quarters.
- CAPTRUST Financial Advisors's ARK Genomic Revolution ETF position peaked at $1.73M in Q3 2021.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.